The total return over the past 12 months is -32.56% vs. +16.94% for the S&P 500. So far it's up -37.59% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (32.56%) | +29.28% | +27.66% | +23.49% | +28.83% | N/A |
| Total Return CAGR | (32.56%) | +29.28% | +27.66% | +23.49% | +28.83% | N/A |
| Revenue CAGR | +21.05% | +38.94% | +34.52% | +33.38% | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | +54.87% | N/A | (10.27%) | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Harrow Health, Inc. (HROW)
| Year | Start price | End price | HROW Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $49.00 | $30.58 | (37.59%) | +14.51% | (52.10%) |
| 2025 | $33.55 | $49.00 | +46.05% | +17.72% | +28.33% |
| 2024 | $11.20 | $33.55 | +199.55% | +24.89% | +174.66% |
| 2023 | $14.76 | $11.20 | (24.12%) | +26.19% | (50.31%) |
| 2022 | $8.64 | $14.76 | +70.83% | (18.17%) | +89.00% |
| 2021 | $6.86 | $8.64 | +25.95% | +28.74% | (2.79%) |
| 2020 | $7.78 | $6.86 | (11.83%) | +18.37% | (30.20%) |
| 2019 | $5.69 | $7.78 | +36.73% | +31.22% | +5.51% |
| 2018 | $1.70 | $5.69 | +234.71% | (4.56%) | +239.27% |
| 2017 | $2.50 | $1.70 | (32.00%) | +21.70% | (53.70%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
